Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health /

Show other versions (1)

The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrict...

Full description

Bibliographic Details
Call Number:Libro Electrónico
Corporate Author: National Research Council (U.S.). Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation
Other Authors: Merrill, Stephen A., Mazza, Anne-Marie
Format: Electronic eBook
Language:Inglés
Published: Washington, D.C. : National Academies Press, ©2006.
Subjects:
Genomics > United States > Patents.
Proteomics > United States > Patents.
Intellectual property > United States.
Genomics.
Proteomics.
Intellectual property.
Public health.
Genomics
Proteomics
Intellectual Property
Patents
Public Health
Génomique > États-Unis > Brevets d'invention.
Protéomique > États-Unis > Brevets d'invention.
Propriété intellectuelle > États-Unis.
Génomique.
Protéomique.
Propriété intellectuelle.
Santé publique.
intellectual property.
public health.
SCIENCE > Life Sciences > Genetics & Genomics.
Public health
Intellectual property
United States
Fulltext.
Internet Resources.
Patents.
patents.
Brevets d'invention.
Online Access:Texto completo
Table of Contents:
  • Genomics, proteomics, and the changing research environment
  • The U.S. patent system, biotechnology, and the courts
  • Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
  • Conclusions and recommendations.

Similar Items